# OrbiMed's Biotech Investments: 176 Startups in Its Portfolio (2026) > The 176 Biotech startups OrbiMed has backed, by stage: $28B raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/orbimed-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Series C and later 46 - [Guardant Health](https://millionrounds.com/company/guardant-health) - [*IM* Insilico Medicine](https://millionrounds.com/company/insilico-medicine) - [Galecto](https://millionrounds.com/company/galecto) - [Star Therapeutics](https://millionrounds.com/company/star-therapeutics) - [Terremoto Biosciences](https://millionrounds.com/company/terremoto-biosciences) - [InventisBio](https://millionrounds.com/company/inventisbio) - [Alector](https://millionrounds.com/company/alector) - [ADCendo](https://millionrounds.com/company/adcendo) - [Aviceda Therapeutics](https://millionrounds.com/company/aviceda-therapeutics) - [Avedro](https://millionrounds.com/company/avedro) - [Alentis Therapeutics](https://millionrounds.com/company/alentis-therapeutics) - [Peloton Therapeutics](https://millionrounds.com/company/peloton-therapeutics) - [Magenta Therapeutics](https://millionrounds.com/company/magenta-therapeutics) - [Sionna Therapeutics](https://millionrounds.com/company/sionna-therapeutics) - [Triveni Bio](https://millionrounds.com/company/triveni-bio) - [Scorpion Therapeutics](https://millionrounds.com/company/scorpion-therapeutics) - [Sonendo](https://millionrounds.com/company/sonendo) - [PMV Pharmaceuticals](https://millionrounds.com/company/pmv-pharmaceuticals) - [*AP* Amolyt Pharma](https://millionrounds.com/company/amolyt-pharma) - [Turnstone Biologics](https://millionrounds.com/company/turnstone-biologics) - [Cerapedics](https://millionrounds.com/company/cerapedics) - [Singulex](https://millionrounds.com/company/singulex) - [*TT* TP Therapeutics](https://millionrounds.com/company/tp-therapeutics) - [ReViral](https://millionrounds.com/company/reviral) +22 more ## Series B 45 - [Terns Pharmaceuticals](https://millionrounds.com/company/terns-pharmaceuticals) - [Intellia Therapeutics](https://millionrounds.com/company/intellia-therapeutics) - [SpringWorks Therapeutics](https://millionrounds.com/company/springworks-therapeutics) - [Passage Bio](https://millionrounds.com/company/passage-bio) - [Acutus Medical](https://millionrounds.com/company/acutus-medical) - [Aeglea BioTherapeutics](https://millionrounds.com/company/aeglea-biotherapeutics) - [Repare Therapeutics](https://millionrounds.com/company/repare-therapeutics) - [Upstream Bio](https://millionrounds.com/company/upstream-bio) - [scPharmaceuticals](https://millionrounds.com/company/scpharmaceuticals) - [*CT* Capstan Therapeutics](https://millionrounds.com/company/capstan-therapeutics) - [Keros Therapeutics](https://millionrounds.com/company/keros-therapeutics) - [Frontera Therapeutics](https://millionrounds.com/company/frontera-therapeutics) - [*AO* Alphamab Oncology](https://millionrounds.com/company/alphamab-oncology) - [Prelude Therapeutics](https://millionrounds.com/company/prelude-therapeutics) - [*HT* Harpoon Therapeutics](https://millionrounds.com/company/harpoon-therapeutics) - [MiroBio](https://millionrounds.com/company/mirobio) - [Achilles Therapeutics](https://millionrounds.com/company/achilles-therapeutics) - [Sidewinder Therapeutics](https://millionrounds.com/company/sidewinder-therapeutics) - [Vigil Neuroscience](https://millionrounds.com/company/vigil-neuroscience) - [MabPlex International](https://millionrounds.com/company/mabplex-international) - [Apollomics](https://millionrounds.com/company/apollomics) - [*I* Imara](https://millionrounds.com/company/imara) - [ProfoundBio](https://millionrounds.com/company/profoundbio) - [*R* Rimag](https://millionrounds.com/company/rimag) +21 more ## Stage not reported 44 - [Apogee Therapeutics](https://millionrounds.com/company/apogee-therapeutics) - [Tyra Biosciences](https://millionrounds.com/company/tyra-biosciences) - [Avalo Therapeutics](https://millionrounds.com/company/avalo-therapeutics) - [*TP* Turning Point Therapeutics](https://millionrounds.com/company/turning-point-therapeutics) - [Enliven Therapeutics](https://millionrounds.com/company/enliven-therapeutics) - [Puma Biotechnology](https://millionrounds.com/company/puma-biotechnology) - [Century Therapeutics](https://millionrounds.com/company/century-therapeutics) - [Dren Bio](https://millionrounds.com/company/dren-bio) - [Janux Therapeutics](https://millionrounds.com/company/janux-therapeutics) - [Valneva](https://millionrounds.com/company/valneva) - [Pionyr Immunotherapeutics](https://millionrounds.com/company/pionyr-immunotherapeutics) - [Nkarta Therapeutics](https://millionrounds.com/company/nkarta-therapeutics) - [Forte Biosciences](https://millionrounds.com/company/forte-biosciences) - [Q32 Bio](https://millionrounds.com/company/q32-bio) - [X4 Pharmaceuticals](https://millionrounds.com/company/x4-pharmaceuticals) - [*EP* Enobia Pharma](https://millionrounds.com/company/enobia-pharma) - [True North Therapeutics](https://millionrounds.com/company/true-north-therapeutics) - [NeuroPace](https://millionrounds.com/company/neuropace) - [TELA Bio](https://millionrounds.com/company/tela-bio) - [Vanqua Bio](https://millionrounds.com/company/vanqua-bio) - [Invivyd](https://millionrounds.com/company/invivyd) - [VectivBio](https://millionrounds.com/company/vectivbio) - [*AB* ARMO BioSciences](https://millionrounds.com/company/armo-biosciences) - [Arvinas](https://millionrounds.com/company/arvinas) +20 more ## Series A 37 - [Erasca](https://millionrounds.com/company/erasca) - [Nuvation Bio](https://millionrounds.com/company/nuvation-bio) - [Verdiva Bio](https://millionrounds.com/company/verdiva-bio) - [89Bio](https://millionrounds.com/company/89bio) - [Rhythm Pharmaceuticals](https://millionrounds.com/company/rhythm-pharmaceuticals) - [Treeline Biosciences](https://millionrounds.com/company/treeline-biosciences) - [AirNexis Therapeutics](https://millionrounds.com/company/airnexis-therapeutics) - [Alpine Immune Sciences](https://millionrounds.com/company/alpine-immune-sciences) - [Braveheart Bio](https://millionrounds.com/company/braveheart-bio) - [Averna Therapeutics](https://millionrounds.com/company/averna-therapeutics) - [GentiBio](https://millionrounds.com/company/gentibio) - [Ottimo Pharma](https://millionrounds.com/company/ottimo-pharma) - [*GT* Gemini Therapeutics](https://millionrounds.com/company/gemini-therapeutics) - [RayThera](https://millionrounds.com/company/raythera) - [OnCusp Therapeutics](https://millionrounds.com/company/oncusp-therapeutics) - [*ET* Emergence Therapeutics](https://millionrounds.com/company/emergence-therapeutics) - [Fusion Pharmaceuticals](https://millionrounds.com/company/fusion-pharmaceuticals) - [Exsilio Therapeutics](https://millionrounds.com/company/exsilio-therapeutics) - [*P* Prevail](https://millionrounds.com/company/prevail) - [*AP* Alizé Pharma 3](https://millionrounds.com/company/alize-pharma-3) - [ProLynx](https://millionrounds.com/company/prolynx) - [Corteria Pharmaceuticals](https://millionrounds.com/company/corteria-pharmaceuticals) - [Adela](https://millionrounds.com/company/adela) - [BioShin](https://millionrounds.com/company/bioshin) +13 more ## Pre-seed and seed 2 - [Renasant Bio](https://millionrounds.com/company/renasant-bio) - [*R* Rhythm](https://millionrounds.com/company/rhythm) ## Growth 2 - [*DK* Dingdang Kuaiyao](https://millionrounds.com/company/dingdang-kuaiyao) - [GC Aesthetics](https://millionrounds.com/company/gc-aesthetics) ## Segment by segment ### Series C and later 46 startups · $6.9B raised - [**Guardant Health**](https://millionrounds.com/company/guardant-health) Guardant Health is a leading precision medicine company focused on transforming patient care and conquering cancer with data. United States $800M - [*IM* **Insilico Medicine**](https://millionrounds.com/company/insilico-medicine) Hong Kong SAR China $392M - [**Galecto**](https://millionrounds.com/company/galecto) Galecto is a clinical stage biotechnology company focused on the development of novel treatments for fibrosis and cancer. Denmark $365M - [**Star Therapeutics**](https://millionrounds.com/company/star-therapeutics) Star Therapeutics is a clinical-stage biotechnology company based in South San Francisco, California, founded in 2018. United States $325M - [**Terremoto Biosciences**](https://millionrounds.com/company/terremoto-biosciences) Terremoto Biosciences is a clinical-stage biotechnology company founded in 2021, focused on covalent drug discovery and development. United States $283M - [**InventisBio**](https://millionrounds.com/company/inventisbio) InventisBio is a clinical-stage biopharmaceutical company based in Shanghai, China, with operations in New Jersey, USA. China $236M - [**Alector**](https://millionrounds.com/company/alector) Alector is a biopharmaceutical company that develops therapies for the treatment of neurodegeneration diseases. United States $215M - [**ADCendo**](https://millionrounds.com/company/adcendo) Adcendo ApS is a clinical-stage biotechnology company based in Frederiksberg, Copenhagen, Denmark, with operational offices in Bos Denmark $210M ### Series B 45 startups · $6.6B raised - [**Terns Pharmaceuticals**](https://millionrounds.com/company/terns-pharmaceuticals) Terns Pharmaceuticals is a biopharmaceutical company that focuses on discovering therapies that will improve the global disease burden. United States $730M - [**Intellia Therapeutics**](https://millionrounds.com/company/intellia-therapeutics) Intellia Therapeutics is a genome editing company that develops curative gene-editing treatments. United States $485M - [**SpringWorks Therapeutics**](https://millionrounds.com/company/springworks-therapeutics) SpringWorks Therapeutics is a biopharmaceutical company that develops medicines for patients with severe rare diseases and cancer. United States $400M - [**Passage Bio**](https://millionrounds.com/company/passage-bio) Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases. United States $380M - [**Acutus Medical**](https://millionrounds.com/company/acutus-medical) Acutus Medical develops medical technologies to treat complex cardiac arrhythmia. United States $268M - [**Aeglea BioTherapeutics**](https://millionrounds.com/company/aeglea-biotherapeutics) Aeglea BioTherapeutics is a clinical-stage biotechnology company that develops enzyme therapies for rare metabolic diseases. United States $266M - [**Repare Therapeutics**](https://millionrounds.com/company/repare-therapeutics) Repare Therapeutics is a developer of oncology drugs designed to target specific vulnerabilities of tumor cells. Canada $252M - [**Upstream Bio**](https://millionrounds.com/company/upstream-bio) Upstream Bio focuses on developing an antibody therapy for the treatment of severe asthma. United States $200M ### Stage not reported 44 startups · $8.5B raised - [**Apogee Therapeutics**](https://millionrounds.com/company/apogee-therapeutics) Apogee Therapeutics is a biotechnology company that offers therapies for immunological and inflammatory disorders. United States $1.3B - [**Tyra Biosciences**](https://millionrounds.com/company/tyra-biosciences) Tyra Biosciences is a biotechnology company targeting new pathways of acquired resistance in oncology with purpose-built drugs. United States $600M - [**Avalo Therapeutics**](https://millionrounds.com/company/avalo-therapeutics) Avalo Therapeutics is a clinical-stage biopharmaceutical company. United States $501M - [*TP* **Turning Point Therapeutics**](https://millionrounds.com/company/turning-point-therapeutics) Turning Point Therapeutics is a pharmaceutical company that discovers and develops precision medicines for cancer and other diseases. - $460M - [**Enliven Therapeutics**](https://millionrounds.com/company/enliven-therapeutics) Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives. United States $460M - [**Puma Biotechnology**](https://millionrounds.com/company/puma-biotechnology) Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer. United States $427M - [**Century Therapeutics**](https://millionrounds.com/company/century-therapeutics) Century Therapeutics is a biotechnology company that develops cell therapies for hematological and solid tumor malignancies. United States $385M - [**Dren Bio**](https://millionrounds.com/company/dren-bio) Dren Bio focuses on protein engineering technologies for depletion of cells, protein aggregates, and other disease-causing agents. United States $375M ### Series A 37 startups · $5.4B raised - [**Erasca**](https://millionrounds.com/company/erasca) Erasca is a developer of oncology drugs intended to provide precision oncology options. United States $739M - [**Nuvation Bio**](https://millionrounds.com/company/nuvation-bio) Nuvation Bio is a global biopharmaceutical company focusing on unmet needs in oncology. United States $675M - [**Verdiva Bio**](https://millionrounds.com/company/verdiva-bio) Verdiva Bio is a clinical-stage biopharmaceutical company based in Guildford, United Kingdom, founded in 2024. United Kingdom $601M - [**89Bio**](https://millionrounds.com/company/89bio) 89bio is a biopharmaceutical company that develops clinical-stage therapies for liver and cardiometabolic diseases. United States $348M - [**Rhythm Pharmaceuticals**](https://millionrounds.com/company/rhythm-pharmaceuticals) Rhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeutics United States $311M - [**Treeline Biosciences**](https://millionrounds.com/company/treeline-biosciences) Treeline Biosciences is a biotech company building transformative precision medicines for patients with cancer and other serious conditions. United States $200M - [**AirNexis Therapeutics**](https://millionrounds.com/company/airnexis-therapeutics) AirNexis Therapeutics develops clinical-stage therapies for chronic obstructive pulmonary disease and other pulmonary conditions. United States $200M - [**Alpine Immune Sciences**](https://millionrounds.com/company/alpine-immune-sciences) Alpine Immune Sciences is an immunotherapy company focused on developing treatments for autoimmune and inflammatory diseases. United States $199M ### Pre-seed and seed 2 startups · $97M raised - [**Renasant Bio**](https://millionrounds.com/company/renasant-bio) Renasant Bio is a biopharmaceutical company based in Berkeley, California, focused on developing oral small molecule therapies for United States $55M - [*R* **Rhythm**](https://millionrounds.com/company/rhythm) United States $42M ### Growth 2 startups · $496M raised - [*DK* **Dingdang Kuaiyao**](https://millionrounds.com/company/dingdang-kuaiyao) Dingdang Kuaiyao is an online-to-offline drug purchasing and delivery platform. China $309M - [**GC Aesthetics**](https://millionrounds.com/company/gc-aesthetics) Há 25 anos a Eurosilicone vem produzindo próteses de silicone, conforme os mais rigorosos padrões de qualidade e segurança e auxil Ireland $187M **How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names OrbiMed as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Sector portfolio **OrbiMed's Pharma portfolio** 26 startups · $3.7B](https://millionrounds.com/portfolio-maps/orbimed-pharma-portfolio)[Sector portfolio **OrbiMed's Healthtech portfolio** 12 startups · $1.4B](https://millionrounds.com/portfolio-maps/orbimed-healthtech-portfolio)[Portfolio map **OrbiMed portfolio map** 221 startups · $34B](https://millionrounds.com/portfolio-maps/orbimed-portfolio-map)[Co-investors **Who invests with OrbiMed** 159 co-investors](https://millionrounds.com/portfolio-maps/orbimed-co-investors)[Sector portfolio **RA Capital Management's Biotech portfolio** 197 startups · $38B](https://millionrounds.com/portfolio-maps/ra-capital-management-biotech-portfolio)[Sector portfolio **Pioneer Fund's AI portfolio** 171 startups · $2.8B](https://millionrounds.com/portfolio-maps/pioneer-fund-2-ai-portfolio) ## Raising from investors like OrbiMed? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)